Skip to main content
. 2015 Jul 23;32(12):3927–3936. doi: 10.1007/s11095-015-1752-9

Table II.

Parameter Values of the Simple (Without Covariates) and Final (With Covariates) Population Pharmacokinetic Models and Results of the Bootstrap Analysis

Parameter Simple model of simultaneous analysis Final model of simultaneous analysis Bootstrap of final simultaneous model
Value (RSE) Value (RSE) Median (2.5–97.5 percentile)
Fixed effects
 Ka = Ktr 0.199 (11%)
 Ka = KtrMorbidly obese (min−1) 0.117 (15%) 0.114 (0.08–0.15)
 Ka = KtrBariatric patients (min−1) 0.267 (19%) 0.263 (0.08–0.45)
 F 0.560 (10%) 0.537 (9%) 0.543 (0.44–0.63)
 CL (L/min) 0.381 (26%)
 CLMorbidly obese (L/min) 0.385 (11%) 0.366 (0.29–0.48)
 fCLBariatric patients(L/min) 1.68 (7%) (* CL morbidly obese= 0.647) 1.70 (1.18–2.18) (* CL morbidly obese= 0.634)
 Q (L/min) 0.888 (21%)
 QMorbidly obese (L/min) 0.669 (24%) 0.764 (0.11–1.23)
 fQBariatric patients (L/min) 3.22 (32%) (* Q Morbidly obese= 2.15) 2.907 (−22.6–29.0) (*Q Morbidly obese= 3.71)
 Q2 0.644 (21%) 0.551(23%) 0.548 (0.25–0.86)
 Vcentral (L) 54.7 (17%)
Vcentral Morbidly obese = Vmedian BW *(1 + X*(BW-median BW))
 Vmedian BW 37.3 (18%) 37.2 (17.8–56.8)
 X 0.0435 (92%) 0.052 (−0.42–0.51)
 Vcentral Bariatric patients (L) 37.3 (18%) 37.2 ()
 V1st peripheral (L) 247 (30%)
VPeripheral Morbidly obese = Vmedian BW*(BW/median BW)Y
 Vmedian BW 106 (17%) 113 (20.9–190.3)
 Y 3.93 (20%) 3.99 (1.9–5.9)
 V1st peripheral Bariatric patients (L) 106 (17%) 113 (1.9–5.9)
 fV2nd peripheral 0.169 (25%) (*V 1st peripheral= 42 L) 0.359 (27%) (*V 1st peripheral= 38 L) 0.311 (0.13–0.58) (*V 1st peripheral= 40 L)
Interindividual variability (%)
 Ktr = Ka 50 (17%) 42.4 (15%) 40.6 (27–54)
 CL 41.5 (24%) 19.7 (38%) 17.7 (−14–32)
 F 28.6 (23%) 33.4 (18%) 32.6 (16–45)
 Vcentral 60.8 (20%) 53.7 (39%) 54.3 (−49–102)
 V1st peripheral 0 FIX 0 FIX 0 FIX
Proportional residual error (%)
46.2 (6%) 42.1 (5%) 41.0 (12.2)
 OFV 6218 5885 5997 (804)

BW body weight (median = 127 kg for all data), CL Clearance (L/min), F Oral bioavailability, fCL Bariatric patients (L/min) fraction of midazolam clearance of morbidly obese patients to estimate bariatic patient clearance, fQ Bariatric patients fraction of intercompartmental clearance of morbidly obese patients to estimate intercompartmental clearance of bariatric patients, fV peripheral fraction of first peripheral volume of distribution to estimate second peripheral volume, Ktr transit compartment rate (min−1), Ka oral absorption rate (min−1), OFV Objective function value (-2LL), Q intercompartmental clearance (L/min), RSE(%) relative standard error, V Volume of distribution (L), V Peripheral first peripheral volume of distribution